缩写名/全名 |
ACTA HAEMATOL-BASEL
ACTA HAEMATOLOGICA |
||||||||||||||||
ISSN号 | 0001-5792 | ||||||||||||||||
研究方向 | 医学-血液学 | ||||||||||||||||
影响因子 | 2015:1.053, 2016:1.205, 2017:1.307, 2018:1.313, 2019:1.196, | ||||||||||||||||
出版国家 | SWITZERLAND | ||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||
年文章数 | 65 | ||||||||||||||||
出版年份 | 1948 | ||||||||||||||||
是否OA | No | ||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||
录用比例 | 容易 | ||||||||||||||||
投稿链接 | http://www.karger.com/Journal/Guidelines/223829 | ||||||||||||||||
投稿官网 | http://www.karger.com/Journal/Home/223829 | ||||||||||||||||
h-index | 53 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0001-5792%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia. Author: Wang L1, Xu J2, Tian X2, Lv T2, Yuan G3. Journal: Acta Haematol. 2019;141(1):43-53. doi: 10.1159/000493250. Epub 2018 Dec 5. PubMed DOI |
2. | Effectiveness and Safety of Deferasirox in Thalassemia with Iron Overload: A Meta-Analysis. Author: Dou H1, Qin Y2, Chen G1, Zhao Y1. Journal: Acta Haematol. 2019;141(1):32-42. doi: 10.1159/000494487. Epub 2018 Nov 30. PubMed DOI |
3. | Hemophagocytic Lymphohistiocytosis during the Postpartum Stage of Pregnancy: A Report of Eight Cases. Author: Song Y1, Wang JS1, Wang YN1, Wang Z2. Journal: Acta Haematol. 2019;141(1):55-60. doi: 10.1159/000493879. Epub 2018 Dec 7. PubMed DOI |
4. | Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases. Author: Li F1, Shu K1, Liu J1, Shen C1, Wang X1, Zhang Z1, Jiang M2. Journal: Acta Haematol. 2019;141(3):148-150. doi: 10.1159/000496080. Epub 2019 Feb 15. PubMed DOI |
5. | Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis. Author: Li Z1, Liu Y2, Wang Q1, Chen L1, Ma L1, Hao S3. Journal: Acta Haematol. 2019;141(3):164-175. doi: 10.1159/000495206. Epub 2019 Feb 26. PubMed DOI |
6. | An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3. Author: Cao Y1, Yao L2, Liu Y1, Gu Q1, Dong W1, Wang Z1, Wang F1, Lin R1, Xie X1, Cen J2, Chen S2, Gu W3. Journal: Acta Haematol. 2019 May 14:1-7. doi: 10.1159/000498842. [Epub ahead of print] PubMed DOI |
7. | Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study. Author: Zhu XF1, He HL2, Wang SQ3, Tang JY4, Han B5, Zhang DH6, Wu LQ7, Wu DP8, Li W9, Xia LH10, Zhu HL11, Liu F12, Shi HX13, Zhang X14, Zhou F15, Hu JD16, Fang JP17, Chen XQ18, Ye TZ19, Liang YM20, Jin J21, Zhang FK22. Journal: Acta Haematol. 2019 May 15:1-9. doi: 10.1159/000499065. [Epub ahead of print] PubMed DOI |
8. | C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges. Author: Du H1, Gao L2, Luan J2, Zhang H2, Xiao T2. Journal: Acta Haematol. 2019 May 16:1-7. doi: 10.1159/000497430. [Epub ahead of print] PubMed DOI |
9. | Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients. Author: Tan J1,2,3, Xue M1,2, Pan J1,2, Cen J1,2, Qi X3, Liu P3, Zhao X3, Wu P3, Wang Q1,2, Liu D1, Liu Y1, Chen S1,2, Wang Z4,5. Journal: Acta Haematol. 2019 May 16:1-8. doi: 10.1159/000495335. [Epub ahead of print] PubMed DOI |
10. | A Novel Mutation at HBB: c.91delA (Codon 30, -A) Causing β-Thalassemia in a Chinese Family. Author: Jia W1, Wang W2, Zhu H3, Chen P4. Journal: Acta Haematol. 2019 May 20:1-4. doi: 10.1159/000499860. [Epub ahead of print] PubMed DOI |
|
|